The acquired brands are well established and recognized among doctors and other members of the medical fraternity in Brazil for their reliability, safety, and trustworthiness
The company has received five final approvals
The company has received six final approvals that includes Chlorpromazine Hydrochloride Tablets
RYALTRIS is a fixed-dose combination therapy that provides relief for the symptoms of SAR, both nasal and ocular, in one easy-to-use nasal spray
The product will be manufactured at Lupin’s facility in Pithampur, India
It has a total of 50 ANDA approvals from USFDA
Glenmark’s current portfolio consists of 173 products authorized for distribution in the U.S. marketplace and 46 ANDA’s pending approval with the U.S. FDA
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)